Cargando…

Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?

PURPOSE: This study aims to evaluate the ability of peritumoral, intratumoral, or combined computed tomography (CT) radiomic features to predict chemotherapy response in non-small cell lung cancer (NSCLC). METHODS: After excluding subjects with incomplete data or other types of treatments, 272 (Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Runsheng, Qi, Shouliang, Zuo, Yifan, Yue, Yong, Zhang, Xiaoye, Guan, Yubao, Qian, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393703/
https://www.ncbi.nlm.nih.gov/pubmed/36003781
http://dx.doi.org/10.3389/fonc.2022.915835
_version_ 1784771328077725696
author Chang, Runsheng
Qi, Shouliang
Zuo, Yifan
Yue, Yong
Zhang, Xiaoye
Guan, Yubao
Qian, Wei
author_facet Chang, Runsheng
Qi, Shouliang
Zuo, Yifan
Yue, Yong
Zhang, Xiaoye
Guan, Yubao
Qian, Wei
author_sort Chang, Runsheng
collection PubMed
description PURPOSE: This study aims to evaluate the ability of peritumoral, intratumoral, or combined computed tomography (CT) radiomic features to predict chemotherapy response in non-small cell lung cancer (NSCLC). METHODS: After excluding subjects with incomplete data or other types of treatments, 272 (Dataset 1) and 43 (Dataset 2, external validation) NSCLC patients who were only treated with chemotherapy as the first-line treatment were enrolled between 2015 and 2019. All patients were divided into response and nonresponse based on the response evaluation criteria in solid tumors, version 1.1. By using 3D slicer and morphological operations in python, the intra- and peritumoral regions of lung tumors were segmented from pre-treatment CT images (unenhanced) and confirmed by two experienced radiologists. Then radiomic features (the first order, texture, shape, et al.) were extracted from the above regions of interest. The models were trained and tested in Dataset 1 and further validated in Dataset 2. The performance of models was compared using the area under curve (AUC), confusion matrix, accuracy, precision, recall, and F1-score. RESULTS: The radiomic model using features from the peritumoral region of 0–3 mm outperformed that using features from 3–6, 6–9, 9–12 mm peritumoral region, and intratumoral region (AUC: 0.95 versus 0.87, 0.86, 0.85, and 0.88). By the fusion of features from 0–3 and 3–6 mm peritumoral regions, the logistic regression model achieved the best performance, with an AUC of 0.97. This model achieved an AUC of 0.85 in the external cohort. Moreover, among the 20 selected features, seven features differed significantly between the two groups (p < 0.05). CONCLUSIONS: CT radiomic features from both the peri- and intratumoral regions can predict chemotherapy response in NSCLC using machine learning models. Combined features from two peritumoral regions yielded better predictions.
format Online
Article
Text
id pubmed-9393703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93937032022-08-23 Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined? Chang, Runsheng Qi, Shouliang Zuo, Yifan Yue, Yong Zhang, Xiaoye Guan, Yubao Qian, Wei Front Oncol Oncology PURPOSE: This study aims to evaluate the ability of peritumoral, intratumoral, or combined computed tomography (CT) radiomic features to predict chemotherapy response in non-small cell lung cancer (NSCLC). METHODS: After excluding subjects with incomplete data or other types of treatments, 272 (Dataset 1) and 43 (Dataset 2, external validation) NSCLC patients who were only treated with chemotherapy as the first-line treatment were enrolled between 2015 and 2019. All patients were divided into response and nonresponse based on the response evaluation criteria in solid tumors, version 1.1. By using 3D slicer and morphological operations in python, the intra- and peritumoral regions of lung tumors were segmented from pre-treatment CT images (unenhanced) and confirmed by two experienced radiologists. Then radiomic features (the first order, texture, shape, et al.) were extracted from the above regions of interest. The models were trained and tested in Dataset 1 and further validated in Dataset 2. The performance of models was compared using the area under curve (AUC), confusion matrix, accuracy, precision, recall, and F1-score. RESULTS: The radiomic model using features from the peritumoral region of 0–3 mm outperformed that using features from 3–6, 6–9, 9–12 mm peritumoral region, and intratumoral region (AUC: 0.95 versus 0.87, 0.86, 0.85, and 0.88). By the fusion of features from 0–3 and 3–6 mm peritumoral regions, the logistic regression model achieved the best performance, with an AUC of 0.97. This model achieved an AUC of 0.85 in the external cohort. Moreover, among the 20 selected features, seven features differed significantly between the two groups (p < 0.05). CONCLUSIONS: CT radiomic features from both the peri- and intratumoral regions can predict chemotherapy response in NSCLC using machine learning models. Combined features from two peritumoral regions yielded better predictions. Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393703/ /pubmed/36003781 http://dx.doi.org/10.3389/fonc.2022.915835 Text en Copyright © 2022 Chang, Qi, Zuo, Yue, Zhang, Guan and Qian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chang, Runsheng
Qi, Shouliang
Zuo, Yifan
Yue, Yong
Zhang, Xiaoye
Guan, Yubao
Qian, Wei
Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
title Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
title_full Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
title_fullStr Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
title_full_unstemmed Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
title_short Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
title_sort predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: peritumoral, intratumoral, or combined?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393703/
https://www.ncbi.nlm.nih.gov/pubmed/36003781
http://dx.doi.org/10.3389/fonc.2022.915835
work_keys_str_mv AT changrunsheng predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined
AT qishouliang predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined
AT zuoyifan predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined
AT yueyong predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined
AT zhangxiaoye predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined
AT guanyubao predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined
AT qianwei predictingchemotherapyresponseinnonsmallcelllungcancerviacomputedtomographyradiomicfeaturesperitumoralintratumoralorcombined